Federal Contractor Profile
Advanced Bioscience Laboratories, INC.
$225.0M obligated·191 awards·1 agencies·12 NAICS
Federal Contracts
Showing contracts 1–50 of 409 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Mar 30, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93018F00009 | 541712 | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES | $495K |
| Mar 30, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93023F00001 | 541715 | QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) SUPPORT | $569K |
| Feb 25, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00001 | 541715 | FEASIBILITY FOR DEVELOPMENT OF A LIPOSOME/LNP DISPLAYING AN HIV ENV TRIMER PROTEIN AND CONTAINING/INCORPORATING AN MRNA. | $1.9M |
| Jan 23, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00001 | 541712 | ESSENTIAL CORE ACTIVITIES III | $180K |
| Sep 23, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00002 | 541715 | EXPERTISE IN USING BITTER TASTE RECEPTOR BLOCKERS TO IMPROVE THE PALATABILITY OF PEDIATRIC MEDICINES: TRAINED HUMAN SENSORY PANELS | $814K |
| Sep 23, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00001 | 541715 | EXPERTISE IN USING BITTER TASTE RECEPTOR BLOCKERS TO IMPROVE THE PALATABILITY OF PEDIATRIC MEDICINES: BLOCKER DISCOVERY | $1.3M |
| Jul 30, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200031 | 541712 | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF CGMP NATIVE FLEXIBLY LINKED HIV-1 ENVELOPE PROTEIN | $186K |
| Jul 3, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93023F00002 | 541715 | MATERIAL AND DATA RECEIPT, STORAGE, SHIPPING, AND INVENTORY | $66K |
| Jun 11, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200003 | 541712 | IGF::OT::IGF PRODUCTION OF ALUMINUM BASED ADJUVANTS | $18K |
| Jun 9, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00001 | 541712 | ESSENTIAL CORE ACTIVITIES III | $333K |
| Jun 6, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200005 | 541712 | IGF::OT::IGF - NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF THE MHRP GP145 CLADE C TRIMER PROTEIN | $25K |
| May 29, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00002 | 541512 | CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN | $3.1M |
| May 1, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93018F00009 | 541712 | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES | $181K |
| Apr 11, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200024 | 541712 | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HCMV-TR3∆PP71 HIVGAG FOR CLINICAL TRIALS | $47K |
| Mar 26, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93023F00001 | 541715 | QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) SUPPORT | $551K |
| Jan 2, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93023F00001 | 541714 | HHSN272201800009I ADVANCED BIOSCIENCE LABORATORIES, INC PROCESS DEVELOPMENT FOR PANFUNGAL VACCINE BASE AWARD CAN 8470036 FOR $159,189.00 CAN 8470038 FOR $318,377.00 TOTAL $477,566.00 | $28K |
| Nov 14, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00002 | 541512 | CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN | $680K |
| Nov 13, 2024 | Department of Health and Human ServicesNIH NCI | 75N91018C00007 | 541380 | IGF::OT::IGF SUPPORT FOR RESEARCH ON RETROVIRAL PATHOGENESIS, TREATMENT, AND PREVENTION | $49K |
| Sep 25, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200015 | 541712 | IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS | $47K |
| Sep 25, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200013 | 541712 | IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS | $114K |
| Sep 25, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00131 | 541712 | CONDUCT STUDY P210 | $12K |
| Sep 25, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200015 | 541712 | IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS | $38K |
| Sep 23, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00002 | 541512 | CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN | $65K |
| Sep 20, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93022F00001 | 541714 | ABL MANUFACTURE AND CHARACTERIZATION SERVICES (MCS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES | $127K |
| Sep 16, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93018F00005 | 541712 | NIAID PRECLINICAL DEVELOPMENT SUPPORT; SYNTHESIZE AND PRODUCE HIV-1 ENVELOPE GLYCPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE(S) | $43K |
| Sep 12, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200001 | 541712 | IGF::OT::IGF ESSENTIAL CORE ACTIVITIES, NIAID PRECLIN DEVELOPMENT SUPPORT | $155K |
| Aug 29, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00132 | 541712 | THE CONTRACTOR SHALL SUPPORT THE ADMINISTRATIVE AND TECHNICAL ACTIVITIES CONDUCTED ON A RECURRING BASIS TO PROVIDE QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) SUPPORT TO TASK ORDERS AWARDED UNDER TASK AREAS A, B, C, AND D. | $24K |
| Aug 29, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200005 | 541712 | IGF::OT::IGF OVINE MODEL AND VAGINAL MICROBIOME SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT. | $3K |
| Aug 29, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00001 | 541715 | FEASIBILITY FOR DEVELOPMENT OF A LIPOSOME/LNP DISPLAYING AN HIV ENV TRIMER PROTEIN AND CONTAINING/INCORPORATING AN MRNA. | $1.9M |
| Aug 28, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00006 | 541715 | EXPERTISE IN THE PRODUCT DEVELOPMENT LIFECYCLE | $537K |
| Aug 6, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00001 | 541714 | KICK-OFF MEETING FOR THE PHARMACOLOGY STUDIES AND ANIMAL MODEL DEVELOPMENT AND RELATED SERVICES FOR DRUG DEVELOPMENT IDIQ CONTRACT | $1K |
| Jul 31, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00005 | 541715 | USE OF ARTIFICIAL INTELLIGENCE/MACHINE LEARNING (AI/ML) TO ENHANCE THE STEP PEDIATRIC EXCIPIENT DATABASE | $1.2M |
| Jul 19, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00003 | 541512 | LEAD CANDIDATE IDENTIFICATION PK AND TOXICOLOGY STUDIES FOR ANTIBODY PROJECT IN BLUEPRINT NEUROTHERAPEUTICS (BPN) BIOLOGICS PROGRAM | $498K |
| Jul 17, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93023F00003 | 541715 | EXPERTISE IN DEVELOPMENT OF PEDIATRIC DRUG FORMULATIONS | $421K |
| Jul 15, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00132 | 541712 | CGMP MANUFACTURING OF GLYCOPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE | $523K |
| Jul 3, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93023F00002 | 541715 | MATERIAL AND DATA RECEIPT, STORAGE, SHIPPING, AND INVENTORY | $64K |
| Jun 28, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00004 | 541715 | PARTICIPATION IN A WORKSHOP ON DEVELOPMENT OF ANIMAL MODELS SUPPORTING PEDIATRIC FORMULATION DEVELOPMENT | $253K |
| Jun 28, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00003 | 541715 | EXPERTISE IN PROFESSIONAL PHARMACEUTICAL PROJECT MANAGEMENT | $693K |
| Jun 25, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00002 | 541715 | EXPERTISE IN USING BITTER TASTE RECEPTOR BLOCKERS TO IMPROVE THE PALATABILITY OF PEDIATRIC MEDICINES: TRAINED HUMAN SENSORY PANELS | $807K |
| Jun 25, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00001 | 541715 | EXPERTISE IN USING BITTER TASTE RECEPTOR BLOCKERS TO IMPROVE THE PALATABILITY OF PEDIATRIC MEDICINES: BLOCKER DISCOVERY | $1.3M |
| Jun 7, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00001 | 541712 | ESSENTIAL CORE ACTIVITIES III | $713K |
| May 31, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93024F00002 | 541712 | LONG-TERM STABILITY TESTING OF A NANOPARTICLE BASED HIV ENVELOPE CONTAINING VACCINE | $626K |
| May 29, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93021F00002 | 541712 | THIS TASK ORDER IS FOR (A) DOWNSTREAM ENGINEERING RUN PRODUCTION, (B) DOWNSTREAM CURRENT GOOD MANUFACTURING PRACTICES MANUFACTURING PRODUCTION (CGMP), (C) FILL/FINISH & LABELING, (D) ANALYTICAL DEVELOPMENT/RELEASE (E) ACCELERATED STABILITY TESTIN | $479K |
| May 21, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200003 | 541712 | IGF::OT::IGF PRODUCTION OF ALUMINUM BASED ADJUVANTS | $208K |
| May 15, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93023F00001 | 541712 | THE TASK ORDER IS TO SUPPORT CGMP MANUFACTURING OF THE PGT121.414.LS MONOCLONAL ANTIBODY (PGT121.414.LS MAB) DRUG SUBSTANCE FROM AN ESTABLISHED MANUFACTURING PROCESS, COMPLETE THE FILL FINISH OF THE DRUG SUBSTANCE (DS) INTO DRUG PRODUCT (DP), QUALITY | $188K |
| May 15, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93022F00001 | 541714 | ABL MANUFACTURE AND CHARACTERIZATION SERVICES (MCS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES | $465K |
| May 15, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | HHSN27200037 | 541712 | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINE | $331K |
| May 8, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93023F00001 | 541714 | HHSN272201800009I ADVANCED BIOSCIENCE LABORATORIES, INC PROCESS DEVELOPMENT FOR PANFUNGAL VACCINE BASE AWARD CAN 8470036 FOR $159,189.00 CAN 8470038 FOR $318,377.00 TOTAL $477,566.00 | $133K |
| Apr 30, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00002 | 541512 | CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN | $3.6M |
| Apr 26, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00134 | 541712 | CHARACTERIZATION OF THE PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) PROFILE OF A CANDIDATE HIV PREVENTION DRUG IN RHESUS MACAQUES | $89K |
Get Alerted Before Advanced Bioscience Laboratories, INC.'s Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free